Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
236 | 48331 | 35.1 | 68% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
236 | 3 | ADENOSINE//NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//ADENOSINE RECEPTORS | 48331 |
409 | 2 | ADENOSINE//ADENOSINE RECEPTORS//ATP | 16639 |
793 | 2 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//NUCLEOSIDES//CARBOCYCLIC NUCLEOSIDES | 12112 |
1752 | 2 | LESCH NYHAN SYNDROME//AMP DEAMINASE//LESCH NYHAN DISEASE | 6485 |
2341 | 2 | RIBONUCLEOTIDE REDUCTASE//POLG//HYDROXYUREA | 4410 |
2798 | 2 | LEFLUNOMIDE//MIZORIBINE//DIHYDROOROTATE DEHYDROGENASE | 3097 |
3150 | 2 | ADENOSINE DEAMINASE//PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY//CECR1 | 2232 |
3291 | 2 | PURINE NUCLEOSIDE PHOSPHORYLASE//CARBOHYDRATE CHEM TEAM//METHIONINE DEPENDENCE | 1872 |
3474 | 2 | DIETARY NUCLEOTIDES//URINARY NUCLEOSIDES//NUCLEOTIDES | 1484 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ADENOSINE | authKW | 483440 | 4% | 36% | 2159 |
2 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | journal | 326423 | 3% | 33% | 1557 |
3 | ADENOSINE RECEPTORS | authKW | 274673 | 2% | 56% | 779 |
4 | NUCLEOSIDES | authKW | 188138 | 2% | 35% | 849 |
5 | ATP | authKW | 172826 | 3% | 21% | 1317 |
6 | PURINES | authKW | 141400 | 1% | 43% | 521 |
7 | P2X7 RECEPTOR | authKW | 136419 | 1% | 72% | 300 |
8 | P2X RECEPTORS | authKW | 136049 | 1% | 69% | 312 |
9 | PURINERGIC SIGNALLING | journal | 124955 | 1% | 68% | 294 |
10 | MOL RECOGNIT SECT | address | 120206 | 1% | 75% | 256 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 34390 | 25% | 1% | 12238 |
2 | Pharmacology & Pharmacy | 30642 | 17% | 1% | 8122 |
3 | Chemistry, Medicinal | 26524 | 8% | 1% | 3683 |
4 | Chemistry, Organic | 23472 | 11% | 1% | 5509 |
5 | Neurosciences | 7504 | 10% | 1% | 4730 |
6 | Physiology | 4117 | 4% | 1% | 2030 |
7 | Biophysics | 3575 | 4% | 1% | 2051 |
8 | Cell Biology | 2163 | 6% | 0% | 2701 |
9 | Medicine, Research & Experimental | 1371 | 3% | 0% | 1560 |
10 | Immunology | 1143 | 4% | 0% | 2088 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL RECOGNIT SECT | 120206 | 1% | 75% | 256 |
2 | REGA MED | 56108 | 1% | 17% | 527 |
3 | AUTON NEUROSCI | 55878 | 0% | 49% | 180 |
4 | RUDOLF BOEHM PHARMACOL TOXICOL | 26678 | 0% | 40% | 106 |
5 | ORGAN BIOORGAN CHEM | 25303 | 0% | 25% | 163 |
6 | AUTONOM NEUROSCI | 23388 | 0% | 50% | 74 |
7 | PHARMA BONN | 18046 | 0% | 46% | 63 |
8 | CARBOHYDRATE CHEM TEAM | 16831 | 0% | 56% | 48 |
9 | SECT MOL NEUROPHARMACOL | 16246 | 0% | 70% | 37 |
10 | UMR 5625 | 15986 | 0% | 44% | 58 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 326423 | 3% | 33% | 1557 |
2 | PURINERGIC SIGNALLING | 124955 | 1% | 68% | 294 |
3 | NUCLEOSIDES & NUCLEOTIDES | 94840 | 1% | 48% | 317 |
4 | JOURNAL OF MEDICINAL CHEMISTRY | 30923 | 2% | 5% | 1053 |
5 | BRITISH JOURNAL OF PHARMACOLOGY | 14703 | 1% | 4% | 667 |
6 | ANTIVIRAL CHEMISTRY & CHEMOTHERAPY | 14130 | 0% | 21% | 106 |
7 | DRUG DEVELOPMENT RESEARCH | 13152 | 1% | 9% | 252 |
8 | BIOCHEMICAL PHARMACOLOGY | 9998 | 1% | 3% | 567 |
9 | ANTIVIRAL RESEARCH | 8974 | 0% | 7% | 227 |
10 | ADVANCES IN ENZYME REGULATION | 8789 | 0% | 15% | 92 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADENOSINE | 483440 | 4% | 36% | 2159 | Search ADENOSINE | Search ADENOSINE |
2 | ADENOSINE RECEPTORS | 274673 | 2% | 56% | 779 | Search ADENOSINE+RECEPTORS | Search ADENOSINE+RECEPTORS |
3 | NUCLEOSIDES | 188138 | 2% | 35% | 849 | Search NUCLEOSIDES | Search NUCLEOSIDES |
4 | ATP | 172826 | 3% | 21% | 1317 | Search ATP | Search ATP |
5 | PURINES | 141400 | 1% | 43% | 521 | Search PURINES | Search PURINES |
6 | P2X7 RECEPTOR | 136419 | 1% | 72% | 300 | Search P2X7+RECEPTOR | Search P2X7+RECEPTOR |
7 | P2X RECEPTORS | 136049 | 1% | 69% | 312 | Search P2X+RECEPTORS | Search P2X+RECEPTORS |
8 | ECTONUCLEOTIDASES | 108771 | 0% | 74% | 233 | Search ECTONUCLEOTIDASES | Search ECTONUCLEOTIDASES |
9 | ADENOSINE A2A RECEPTOR | 105508 | 1% | 61% | 273 | Search ADENOSINE+A2A+RECEPTOR | Search ADENOSINE+A2A+RECEPTOR |
10 | P2X7 | 99699 | 0% | 79% | 201 | Search P2X7 | Search P2X7 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RALEVIC, V , BURNSTOCK, G , (1998) RECEPTORS FOR PURINES AND PYRIMIDINES.PHARMACOLOGICAL REVIEWS. VOL. 50. ISSUE 3. P. 413 -492 | 745 | 78% | 2841 |
2 | BURNSTOCK, G , (2007) PHYSIOLOGY AND PATHOPHYSIOLOGY OF PURINERGIC NEUROTRANSMISSION.PHYSIOLOGICAL REVIEWS. VOL. 87. ISSUE 2. P. 659 -797 | 913 | 54% | 748 |
3 | BURNSTOCK, G , KNIGHT, GE , (2004) CELLULAR DISTRIBUTION AND FUNCTIONS OF P2 RECEPTOR SUBTYPES IN DIFFERENT SYSTEMS.INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL. 240. VOL. 240. ISSUE . P. 31 -+ | 1233 | 52% | 382 |
4 | NORTH, RA , (2002) MOLECULAR PHYSIOLOGY OF P2X RECEPTORS.PHYSIOLOGICAL REVIEWS. VOL. 82. ISSUE 4. P. 1013-1067 | 404 | 80% | 1767 |
5 | KACZMAREK-HAJEK, K , LORINCZI, E , HAUSMANN, R , NICKE, A , (2012) MOLECULAR AND FUNCTIONAL PROPERTIES OF P2X RECEPTORS-RECENT PROGRESS AND PERSISTING CHALLENGES.PURINERGIC SIGNALLING. VOL. 8. ISSUE 3. P. 375 -417 | 490 | 87% | 64 |
6 | BURNSTOCK, G , RALEVIC, V , (2014) PURINERGIC SIGNALING AND BLOOD VESSELS IN HEALTH AND DISEASE.PHARMACOLOGICAL REVIEWS. VOL. 66. ISSUE 1. P. 102 -192 | 707 | 47% | 68 |
7 | CODDOU, C , YAN, ZH , OBSIL, T , HUIDOBRO-TORO, JP , STOJILKOVIC, SS , (2011) ACTIVATION AND REGULATION OF PURINERGIC P2X RECEPTOR CHANNELS.PHARMACOLOGICAL REVIEWS. VOL. 63. ISSUE 3. P. 641 -683 | 428 | 81% | 173 |
8 | BOURS, MJL , SWENNEN, ELR , DI VIRGILIO, F , CRONSTEIN, BN , DAGNELIE, PC , (2006) ADENOSINE 5 '-TRIPHOSPHATE AND ADENOSINE AS ENDOGENOUS SIGNALING MOLECULES IN IMMUNITY AND INFLAMMATION.PHARMACOLOGY & THERAPEUTICS. VOL. 112. ISSUE 2. P. 358 -404 | 491 | 73% | 458 |
9 | BURNSTOCK, G , BOEYNAEMS, JM , (2014) PURINERGIC SIGNALLING AND IMMUNE CELLS.PURINERGIC SIGNALLING. VOL. 10. ISSUE 4. P. 529 -564 | 415 | 76% | 26 |
10 | BURNSTOCK, G , KRUGEL, U , ABBRACCHIO, MP , ILLES, P , (2011) PURINERGIC SIGNALLING: FROM NORMAL BEHAVIOUR TO PATHOLOGICAL BRAIN FUNCTION.PROGRESS IN NEUROBIOLOGY. VOL. 95. ISSUE 2. P. 229 -274 | 433 | 63% | 144 |
Classes with closest relation at Level 3 |